Abstract

Background. Coronavirus disease 2019 (COVID-19) has been a global threat that pushes healthcare to its limits. Hypertension is one of the most common risk factors for cardiovascular complications in COVID-19 and is strongly associated with disease severity and mortality. To date, clinical mechanisms by which hypertension leads to increased risk in COVID-19 are still unclear. Furthermore, additional factors might increase these risks, such as the consideration of age and sex, which are of interest when in search of personalized treatments for hypertensive COVID-19 patients. Methods. We conducted a retrospective cohort study of 543 COVID-19 patients in seven provinces of China to examine the epidemiological and clinical characteristics of COVID-19 in this population and to determine risk factors of hypertensive COVID-19 patients. We also used univariable and multivariable logistic regression methods to explore the risk factors associated with hypertensive COVID-19 patients in different age and sex subgroups. Results. Among the enrolled COVID-19 patients, the median age was 47 years (interquartile range (IQR) 34.0–57.0), and 99 patients (18.23%) were over 60 years old. With regard to comorbidities, 91 patients (16.75%) were diagnosed with hypertension, followed by diabetes, coronary disease, and cerebrovascular disease. Of the hypertensive COVID-19 patients, 51 (56.04%) were male. Multivariable analysis showed that old age, comorbid diabetes or coronary heart disease on admission, increased D-dimer, increased glucose, and decreased lymphocyte count were independent risk factors associated with hypertensive COVID-19 patients. Elevated total bilirubin (odds ratio [OR]: 1.014, 95% confidence interval [CI]: 0.23–1.05; p=0.043) and triglycerides (OR: 1.173, 95% CI: 0.049–1.617; p=0.007) were found to be associated with elderly hypertensive COVID-19 patients. In addition, we found that decreased lymphocytes, basophil, high-density lipoprotein, and increased fibrinogen and creatinine were related to a higher risk of disease severity in male patients. The most common abnormal clinical findings pertaining to female hypertensive COVID-19 patients were hemoglobin, total bile acid, total protein, and low-density lipoprotein. Conclusions. Factors associated with increased risk of hypertensive COVID-19 patients were identified. Results to the different age and sex subgroups in our study will allow for better possible personalized care and also provide new insights into specific risk stratification, disease management, and treatment strategies for COVID-19 patients with hypertension in the future.

Details

Title
Retrospective Study of Aging and Sex-Specific Risk Factors of COVID-19 with Hypertension in China
Author
Wang, Juan 1   VIAFID ORCID Logo  ; Zhang, Yili 2   VIAFID ORCID Logo  ; Li, Kexin 3 ; Du, KangJia 2 ; Huang, Xinyi 2 ; Zhou, Zifeng 2 ; Ma, Yan 4 ; Guo, Shuzhen 2 ; Hou, Yong 5 ; Li, Quntang 6 ; Xu, Hongming 7 ; Huang, Jin 8 ; Huang, Qiuhua 8 ; Na, Hui 9 ; Wang, Jingwei 9 ; Wang, Xiaoyan 10 ; Xiao, Yanhua 11 ; Zhu, Junteng 12 ; Chen, Hong 13 ; Zhang, Liu 14 ; Wang, Mingxuan 15 ; Zhang, Linsong 16 ; Wang, Wei 17   VIAFID ORCID Logo  ; Wan, Haitong 1   VIAFID ORCID Logo 

 School of Life and Health Sciences, Zhejiang Chinese Medical University, Hangzhou, China 
 School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 
 Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China 
 Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China 
 The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, Anhui, China 
 Chongqing Traditional Chinese Medicine Hospital, Chongqing, China 
 Department of Infectious Disease, Daqing Second Hospital, Daqing, Heilongjiang, China 
 Department of Traditional Chinese Medicine, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China 
 Department of Infectious Disease, Harbin Infectious Disease Hospital, Harbin, Heilongjiang, China 
10  Department of Infectious Disease, Jinzhong Infectious Disease Hospital, Jinzhong, Shanxi, China 
11  Department of Traditional Chinese Medicine, Mudanjiang Kangan Hospital, Mudanjiang, Heilongjiang, China 
12  Department of Rehabilitation Medicine, The Affiliated Hospital of Putian College, Putian, Fujian, China 
13  President’s Office, The First Hospital of Qiqihar, Qiqihar, Heilongjiang, China 
14  Department of Traditional Chinese Medicine, The First Hospital of Suihua City, Suihua, Heilongjiang, China 
15  Department of Traditional Chinese Medicine, Suining Central Hospital, Suining, Sichuan, China 
16  Department of Traditional Chinese Medicine, Hospital (T·C·M) Affiliated to Southwest Medical University, Luzhou, Sichuan, China 
17  President’s Office, Beijing University of Chinese Medicine, Beijing, China 
Editor
Victor Garcia
Publication year
2022
Publication date
2022
Publisher
John Wiley & Sons, Inc.
ISSN
17555914
e-ISSN
17555922
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2687539224
Copyright
Copyright © 2022 Juan Wang et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0/